Benitec Biopharma Inc.BNTCNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+13.9%
5Y CAGR+21.9%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+13.9%/yr
vs +55.7%/yr prior
5Y CAGR
+21.9%/yr
Recent deceleration
Acceleration
-41.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.7x
Strong expansion
Streak
7 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$18.88M+3.0%
2025$18.33M+17.4%
2024$15.61M+22.2%
2023$12.77M+13.3%
2022$11.27M+60.6%
2021$7.02M+133.9%
2020$3.00M+38.0%
2019$2.17M-57.0%
2018$5.06M-4.9%
2017$5.32M-